AXT, Inc. (AXTI) manufactures compound semiconductor wafer substrates — indium phosphide, gallium arsenide and germanium — that sit at the base of the lasers and optical components powering AI data-center connectivity. Its shares were trading at $32.00 on Friday, down $2.84, or 8.15%, from the prior close of $34.84. The move was unambiguously negative and extended a slide that has erased roughly four-fifths of the stock's peak value. No company-specific press release, filing or earnings event was identified as the trigger; the decline is best explained by renewed fears of U.S. restrictions on Chinese optical hardware, analyst caution on export-permit dependency, and a broader de-rating of high-multiple AI optics names.
The dominant narrative around AXTI is regulatory, not operational. AXT produces essentially all of its indium phosphide substrates in China and needs Beijing's approval for every shipment abroad — a requirement that dates to China's addition of indium phosphide to its export-control list in February 2025. Management has said permit flow has improved materially, but the market continues to price the tail risk that Washington's tightening of chip-related rules provokes retaliation.
That risk resurfaced this week as investors focused on potential U.S. restrictions covering China-manufactured optical transceiver modules, with reports indicating any rulemaking would most likely target next-generation 3.2-terabit parts rather than current 800G and 1.6T products. Because AXT's substrates feed those modules, headlines in that channel move the stock disproportionately, even when the direct revenue exposure is limited. The same theme has weighed on optics peers throughout November.
Sentiment was already fragile after B. Riley lowered its price target on AXT to $43 from $56 while keeping a Neutral rating, citing the fragility of the permit regime and the risk that customers such as Lumentum and Coherent qualify non-Chinese suppliers including Germany's Freiberger. The note cut the valuation multiple applied to the business to 3.5 times 2028 revenue from 5.0 times — a mechanical compression of the price investors are willing to pay for the growth story, and one that lands hardest on a stock trading at a premium multiple.
Fundamentals themselves remain strong: third-quarter revenue reached a record $73.4 million, up 162% year over year, non-GAAP earnings of $0.41 per share beat consensus, and management guided fourth-quarter revenue to about $90 million with backlog above $500 million. The disconnect is valuation, not demand.
The current leg lower began in October, when AXT moved to raise roughly $550 million in a public offering of common stock to fund indium phosphide capacity expansion. Equity issuance at a high share price increases the float and resets the supply-demand balance for a stock that had already run from roughly $14 to $143 within the year. Add continued insider sales and a short position of about 13 million shares, and the tape becomes dominated by sellers rotating out of a crowded momentum position. Every bounce since — including a 19.5% rally on November 11 — has been sold.
Trading has been consistently heavy during the decline, with recent sessions ranging from about 4 million to more than 13 million shares against an average near 10 million, indicating that the selling reflects real position reduction rather than a thin order book. Friday's early turnover added to that pattern.
The move was only partly idiosyncratic. Photonics and AI-optics names have swung sharply alongside a broader reassessment of AI-infrastructure valuations, and AXT's high beta to that theme means sector headlines translate into outsized single-stock moves. Technicals reinforce the bearish read: shares broke below the $34 area that had held as support on November 18 and 19, and sit far below their 20-day and 50-day moving averages.
A score of 0 would describe no meaningful news and a price move that is ordinary for the stock; 100 would describe transformative news and an extreme, rare move. AXT earns 20 out of 100.
The verified news is modest: a single analyst target cut and multiple compression, set against macro and regulatory headlines rather than a company disclosure. The price action is also unremarkable by AXT's own standards. The stock's average absolute daily move over the last 60 sessions is about 6.6%, and Friday's 8.15% decline is roughly 1.2 times that figure. Eighteen of those 60 sessions produced an equal or larger move. Weak news combined with a routine-sized move for this name produces a low score.
Attention now turns to fourth-quarter results, with management guiding to roughly $90 million in revenue and investors focused on whether indium phosphide pricing and 4-inch wafer migration can sustain margin expansion above 50%. Export-permit cadence from Beijing remains the single most important swing factor for shipments and will be scrutinized on the next call. Analysts will also watch whether AXT's planned Hong Kong listing of subsidiary Tongmei progresses after the Shanghai route was shelved. Sector developments — hyper-scaler capital spending, 1.6T transceiver ramps and any formal U.S. rulemaking on China-built optical modules — are likely to drive sentiment in the interim. Key risks include customer qualification of non-Chinese substrate suppliers, dilution from the recent offering, and continued insider selling.
Tickeron's Trending AI Robots page offers a curated view of automated strategies that are performing best under present market conditions. Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, and only the strongest current performers are featured in this section. Bots differ by strategy, timeframe, performance metrics and the symbols they trade, so the list changes as market conditions evolve. Reviewing the trending lineup is a practical way to see which approaches are working right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 50-day moving average for AXTI moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXTI as a result. In 68 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for AXTI turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 36 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
The 10-day moving average for AXTI crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AXTI entered a downward trend on November 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for AXTI's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +16.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in 217 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
AXTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.885) is normal, around the industry mean (5.670). AXTI's P/E Ratio (1296.000) is considerably higher than the industry average of (68.795). AXTI's Projected Growth (PEG Ratio) (0.100) is slightly lower than the industry average of (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (26.596) is also within normal values, averaging (27.897).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment